This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects:

Chemicals Low‑importance This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles Low This article has been rated as Low-importance on the project's importance scale. Pharmacology Low‑importance This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles Low This article has been rated as Low-importance on the project's importance scale.

The API compound, nameed FCN005, was first synthesized by chemist Tongshuang Li at Fochon Pharma in 2009. The process of the compound was also developed by the chemists at Fochon Pharma. A patent was granted in United States in 2014, see https://patents.google.com/patent/US8648073B2/en?oq=US+8%2c648%2c073+B2 Tongshuangli ( talk) 17:35, 16 November 2023 (UTC) reply

IUPAC name: (R)-2-((3-(3-aminopiperidin-1-yl)-6-methyl-5-oxo-1,2,4-triazin-4(5H)-yl)methyl)-4-fluorobenzonitrile benzoate SMILES (free base): CC(C1=O)=NN=C(N2C[C@@H](CCC2)N)N1CC3=C(C=CC(F)=C3)C#N CAS No.: 1312954-58-7 Formula (free base): C₁₇H₁₉FN₆O Molecular Weight (free base): 342.37 Tongshuangli ( talk) 17:58, 16 November 2023 (UTC) reply